PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Blood thinners and psilocybin.

6 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

6Records
0With human data

Also searched as blood thinner · anticoagulant · antiplatelet

01 What the evidence covers

Best evidence available per medication
6No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Apixaban · EliquisEvidence: No psilocybin data

    Stroke prevention in atrial fibrillation (not caused by a heart valve problem); Blood clot prevention after hip or knee replacement

    Not studied with psilocybin. Also, it raises bleeding risk if a fall or injury occurs, and stopping it early raises stroke and clot risk.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Aspirin · Bayer, Ecotrin, BufferinEvidence: No psilocybin data

    Minor aches and pains (headache, muscle pain, toothache, menstrual pain, arthritis); Fever

    Not studied with psilocybin; no linking mechanism is described. Also, it raises bleeding risk, more so with blood thinners or steroids.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Clopidogrel · PlavixEvidence: No psilocybin data

    Acute coronary syndrome (unstable angina and heart attack), to reduce heart attack and stroke; Recent heart attack, recent stroke or peripheral artery disease, to reduce heart attack and stroke

    Not studied with psilocybin; no linking mechanism is described. It raises bleeding risk, so a fall while coordination is impaired may cause more injury.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Rivaroxaban · XareltoEvidence: No psilocybin data

    Stroke prevention in atrial fibrillation (not caused by valve disease); Deep vein thrombosis and pulmonary embolism, treatment and recurrence prevention

    Not studied with psilocybin; no linking mechanism is described. Also, it raises bleeding risk, and stopping it early raises the risk of blood clots.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ticagrelor · BrilintaEvidence: No psilocybin data

    Lowering risk of heart attack, stroke and cardiovascular death after acute coronary syndrome or a prior heart attack; Lowering risk of a first heart attack or stroke in high-risk coronary artery disease

    Not studied with psilocybin; it raises bleeding risk from falls or injuries. Also, stopping it raises the risk of heart and blood-vessel events.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Warfarin · Coumadin, JantovenEvidence: No psilocybin data

    Blood clots in veins (venous thrombosis) and pulmonary embolism (prevention and treatment); Clot complications from atrial fibrillation or heart valve replacement

    Not studied with psilocybin; no linking mechanism is described; it raises bleeding risk, so a fall during a session can cause serious bleeding.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
3Withdrawal or rebound if stopped abruptly

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
6Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
6Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.

Records reviewed 2026-10-03. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25